HistoGeneX N.V.

Where the EU money came from

Funding by EU programme. Amounts are HistoGeneX N.V.'s own share of each project, not the project's full budget.

Projects

2 EU-funded projects, newest first. Each links to the official record.

• OncoProToolsAssociated partner

  Protease‐guided tumor targeting tools to revolutionize cancer diagnosis and treatment.

  Horizon Europe · 2022–2026 · Project on CORDIS ↗
• MOGLYNETPartner

  Modulation of glycolytic flux as a new approach for treatment of atherosclerosis and plaque stabilization: a multidisciplinary study

  Horizon 2020 · 2015–2019 · Project on CORDIS ↗

Works most with

Organisations that shared the most EU projects with this one. A good starting list for consortium partners.

• Universiteit AntwerpenBelgium · 2 shared projects
• Agencia Estatal Consejo Superior de Investigaciones CientificasSpain · 1 shared project
• Kobenhavns UniversitetDenmark · 1 shared project
• Alma Mater Studiorum - Universita di BolognaItaly · 1 shared project
• Technische Universitaet DresdenGermany · 1 shared project
• Academisch Ziekenhuis LeidenNetherlands · 1 shared project
• Universitat de BarcelonaSpain · 1 shared project
• Universita Degli Studi di MilanoItaly · 1 shared project
• Universitaet BernSwitzerland · 1 shared project
• Johannes Gutenberg-Universitat MainzGermany · 1 shared project
• Universidad Autonoma de MadridSpain · 1 shared project
• Helmholtz-Zentrum Dresden-Rossendorf eVGermany · 1 shared project
• The University Court of the University of AberdeenUnited Kingdom · 1 shared project
• Semmelweis EgyetemHungary · 1 shared project
• Faculdade de Farmácia da Universidade de LisboaPortugal · 1 shared project
• Biomax Informatics AGGermany · 1 shared project

Fields it works in

Research fields recorded on its Horizon projects.

• arteriosclerosis
• cells technologies
• drug discovery
• medicinal chemistry
• nuclear medicine
• oncology
• stroke